Advertisement
Screener

EDESA BIOTECH, INC. (EDSA) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

EDESA BIOTECH, INC. Stock-Based Compensation

EDESA BIOTECH, INC. (EDSA) reported Stock-Based Compensation of $1.43 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-13

  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $547.46K, a 208.64% increase year-over-year.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $484.85K, a 627.43% increase year-over-year.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $399.86K, a 392.54% increase year-over-year.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $404.43K, a 330.55% increase year-over-year.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $729.64K, a 35.75% increase from fiscal 2024.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $537.49K, a 56.88% decline from fiscal 2023.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $1.25M, a 44.86% decline from fiscal 2022.
  • EDESA BIOTECH, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.26M, a 29.26% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 1 monthShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$547.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13
$1.03M
derived: sum of 2 quarters · filed 2026-08-13
$1.43M
10-Q · filed 2026-08-13
$1.84M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$484.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14
$884.72K
10-Q · filed 2026-05-14
$1.29M
derived: sum of 3 quarters · filed 2026-05-14
$1.47M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$399.86K
10-Q · filed 2026-02-13
$804.29K
derived: sum of 2 quarters · filed 2026-02-13
$981.67K
derived: sum of 3 quarters · filed 2026-08-13
$1.05M
derived: sum of 4 quarters · filed 2026-08-13
2025-09-30$404.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12
$581.81K
derived: sum of 2 quarters · filed 2026-08-13
$648.46K
derived: sum of 3 quarters · filed 2026-08-13
$729.64K
10-K · filed 2025-12-12
2025-06-30$177.38K
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13
$244.03K
derived: sum of 2 quarters · filed 2026-08-13
$325.22K
10-Q · filed 2026-08-13
$419.15K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$66.65K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14
$147.84K
10-Q · filed 2026-05-14
$241.77K
derived: sum of 3 quarters · filed 2026-05-14
$351.27K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$81.18K
10-Q · filed 2026-02-13
$175.12K
derived: sum of 2 quarters · filed 2026-02-13
$284.62K
derived: sum of 3 quarters · filed 2026-02-13
$434.32K
derived: sum of 4 quarters · filed 2026-02-13
2024-09-30$93.93K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12
$203.44K
derived: sum of 2 quarters · filed 2025-12-12
$353.13K
derived: sum of 3 quarters · filed 2025-12-12
$537.49K
10-K · filed 2025-12-12
2024-06-30$109.51K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08
$259.20K
derived: sum of 2 quarters · filed 2025-08-08
$443.56K
10-Q · filed 2025-08-08
$960.64K
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$149.70K
10-Q · filed 2024-05-10
$334.05K
10-Q · filed 2025-05-14
$851.13K
derived: sum of 3 quarters · filed 2025-02-14
$959.29K
derived: sum of 4 quarters · filed 2025-02-14
2023-12-31$184.36K
10-Q · filed 2025-02-14
$701.43K
derived: sum of 2 quarters · filed 2025-02-14
$809.59K
derived: sum of 3 quarters · filed 2025-02-14
$1.10M
derived: sum of 4 quarters · filed 2025-02-14
2023-09-30$517.08K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13
$625.24K
derived: sum of 2 quarters · filed 2024-12-13
$912.78K
derived: sum of 3 quarters · filed 2024-12-13
$1.25M
10-K · filed 2024-12-13
2023-06-30$108.16K
10-Q · filed 2023-08-09
$395.71K
derived: sum of 2 quarters · filed 2024-05-10
$729.38K
10-Q · filed 2024-08-09
$1.19M
derived: sum of 4 quarters · filed 2024-05-10
2023-03-31$287.55K
10-Q · filed 2024-05-10
$621.22K
10-Q · filed 2024-05-10
$1.08M
derived: sum of 3 quarters · filed 2024-05-10
$1.64M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$333.68K
10-Q · filed 2024-02-09
$789.64K
derived: sum of 2 quarters · filed 2024-02-09
$1.36M
derived: sum of 3 quarters · filed 2024-02-09
$1.99M
derived: sum of 4 quarters · filed 2024-02-09
2022-09-30$455.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15
$1.02M
derived: sum of 2 quarters · filed 2023-12-15
$1.65M
derived: sum of 3 quarters · filed 2023-12-15
$2.26M
10-K · filed 2023-12-15
2022-06-30$565.38K
10-Q · filed 2023-08-09
$1.20M
derived: sum of 2 quarters · filed 2023-08-09
$1.80M
10-Q · filed 2023-08-09
$2.71M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$630.01K
10-Q · filed 2023-05-11
$1.24M
10-Q · filed 2023-05-11
$2.14M
derived: sum of 3 quarters · filed 2023-05-11
$3.24M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$609.28K
10-Q · filed 2023-02-10
$1.51M
derived: sum of 2 quarters · filed 2023-02-10
$2.61M
derived: sum of 3 quarters · filed 2023-02-10
$3.08M
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30$904.67K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16
$2.01M
derived: sum of 2 quarters · filed 2022-12-16
$2.47M
derived: sum of 3 quarters · filed 2022-12-16
$3.20M
10-K · filed 2022-12-16
2021-06-30$1.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12
$1.57M
derived: sum of 2 quarters · filed 2022-08-12
$2.29M
10-Q · filed 2022-08-12
$2.38M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$467.44K
10-Q · filed 2021-05-14
$1.19M
10-Q · filed 2022-05-13
$1.28M
derived: sum of 3 quarters · filed 2022-02-14
$1.29M
derived: sum of 4 quarters · filed 2022-02-14
2020-12-31$722.91K
10-Q · filed 2022-02-14
$809.30K
derived: sum of 2 quarters · filed 2022-02-14
$820.72K
derived: sum of 3 quarters · filed 2022-02-14
$1.20M
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30$86.39K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28
$97.81K
derived: sum of 2 quarters · filed 2021-12-28
$477.81K
derived: sum of 3 quarters · filed 2021-12-28
$598.36K
10-K · filed 2021-12-28
2020-06-30$11.42K
10-Q · filed 2020-08-12
$391.42K
derived: sum of 2 quarters · filed 2021-05-14
$511.97K
10-Q · filed 2021-08-13
$410.40K
derived: sum of 4 quarters · filed 2021-05-14
2020-03-31$380.00K
10-Q · filed 2021-05-14
$388.77K
10-Q · filed 2021-05-14
$398.98K
derived: sum of 3 quarters · filed 2021-05-14
$522.17K
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$8.78K
10-Q · filed 2021-02-16
$18.98K
derived: sum of 2 quarters · filed 2021-02-16
$142.17K
derived: sum of 3 quarters · filed 2021-02-16
$155.62K
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30$10.21K
derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07
$133.40K
derived: sum of 2 quarters · filed 2020-12-07
$35.07K
10-K · filed 2020-12-07
$158.28K
derived: sum of 4 quarters · filed 2020-12-07
2019-06-30$123.19K
10-Q · filed 2020-08-12
$11.00K
10-Q · filed 2019-08-14
$24.87K
10-Q · filed 2019-08-14
$36.30K
10-Q · filed 2020-08-12
$176.97K
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$13.45K
10-Q · filed 2020-05-15
$24.88K
10-Q · filed 2020-05-15
$45.20K
10-Q · filed 2019-05-08
$53.78K
derived: sum of 3 quarters · filed 2020-05-15
$76.78K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$11.43K
10-Q · filed 2020-02-13
$27.04K
10-Q · filed 2019-02-05
$40.34K
derived: sum of 2 quarters · filed 2020-02-13
$63.34K
derived: sum of 3 quarters · filed 2020-02-13
$81.34K
10-KT · filed 2019-12-12
2018-09-30$28.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30
$51.90K
derived: sum of 2 quarters · filed 2019-08-14
$125.37K
derived: sum of 3 quarters · filed 2019-08-14
$154.31K
10-K · filed 2018-11-30
2018-06-30$23.00K
10-Q · filed 2019-08-14
$46.68K
10-Q · filed 2019-08-14
$125.41K
10-Q · filed 2018-08-08
$140.23K
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$73.46K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08
$94.17K
10-Q · filed 2019-05-08
$117.23K
derived: sum of 3 quarters · filed 2019-05-08
$144.92K
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$20.71K
10-Q · filed 2019-02-05
$43.77K
derived: sum of 2 quarters · filed 2019-02-05
$71.46K
derived: sum of 3 quarters · filed 2019-02-05
$99.81K
derived: sum of 4 quarters · filed 2019-02-05
2017-09-30$23.07K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30
$50.75K
derived: sum of 2 quarters · filed 2018-11-30
$79.10K
derived: sum of 3 quarters · filed 2018-11-30
$115.55K
10-K · filed 2018-11-30
2017-06-30$27.69K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08
$56.04K
derived: sum of 2 quarters · filed 2018-08-08
$92.48K
10-Q · filed 2018-08-08
$142.08K
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$28.35K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07
$64.79K
10-Q · filed 2018-05-07
$114.39K
derived: sum of 3 quarters · filed 2018-05-07
$156.84K
derived: sum of 4 quarters · filed 2018-05-07
2016-12-31$36.44K
10-Q · filed 2018-02-07
$86.04K
derived: sum of 2 quarters · filed 2018-02-07
$128.49K
derived: sum of 3 quarters · filed 2018-02-07
$171.32K
derived: sum of 4 quarters · filed 2018-02-07
2016-09-30$49.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01
$92.05K
derived: sum of 2 quarters · filed 2017-12-01
$134.88K
derived: sum of 3 quarters · filed 2017-12-01
$259.38K
10-K · filed 2017-12-01
2016-06-30$42.45K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09
$85.28K
derived: sum of 2 quarters · filed 2017-08-09
$209.78K
10-Q · filed 2017-08-09
$232.22K
derived: sum of 4 quarters · filed 2017-12-01
2016-03-31$42.83K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09
$167.33K
10-Q · filed 2017-05-09
$189.77K
derived: sum of 3 quarters · filed 2017-12-01
$235.62K
derived: sum of 4 quarters · filed 2017-12-01
2015-12-31$124.50K
10-Q · filed 2017-02-06
$146.94K
derived: sum of 2 quarters · filed 2017-12-01
$192.79K
derived: sum of 3 quarters · filed 2017-12-01
$304.85K
derived: sum of 4 quarters · filed 2017-12-01
2015-09-30$22.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01
$68.30K
derived: sum of 2 quarters · filed 2017-12-01
$180.36K
derived: sum of 3 quarters · filed 2017-12-01
$267.22K
10-K · filed 2017-12-01
2015-06-30$45.85K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
$157.92K
derived: sum of 2 quarters · filed 2016-08-09
$244.78K
10-Q · filed 2016-08-09
2015-03-31$112.06K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09
$198.93K
10-Q · filed 2016-05-09
2014-12-31$86.86K
10-Q · filed 2016-02-08
2014-09-30$36.51K
10-K · filed 2016-12-14
2014-08-31$956.63K
10-K · filed 2016-12-14
2014-06-30$156.47K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10
$302.06K
derived: sum of 2 quarters · filed 2015-08-10
$770.78K
10-Q · filed 2015-08-10
2014-03-31$145.59K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11
$614.31K
10-Q · filed 2015-05-11
2013-12-31$468.72K
10-Q · filed 2015-02-09
2013-08-31$786.59K
10-K · filed 2015-12-14
2012-08-31$1.92M
10-K · filed 2014-11-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Celularity Inc (CELU)United States$0.038B-0.34
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Kairos Pharma, LTD. (KAPA)United States$0.041B